The documented research dose is ~2.33 mg of total blend per administration, which for a 70 mg vial reconstituted in 3 mL equals 0.10 mL, or 10 units on a U-100 syringe
AHK-Cu's enhanced DPC proliferation means it is better at activating and sustaining this command center
Morita S, Yano M, Tsujinaka T, Ogawa A, Taniguchi M, Kaneko K, Shiozaki H, Doki Y, Inoue M, Morden M
providers to ensure treatment is safe, effective, and personalized to your needs
If you are managing psoriasis and exploring peptide research, membership gives you access to the tools and knowledge base needed to make informed decisions alongside your healthcare provider
Improved detection of the KIT D816V mutation in patients with systemic mastocytosis using a quantitative and highly sensitive real-time qPCR assay